Browse ChIP/chip in vivo Binding Data - Release 2.1

You may browse our data in the UCSC Genome Browser using release 4 coordinates or release 5 coordinates

The table below shows a summary of the ChIP-chip experiments that are available in this release. Most data is for Stage 5, but for some factors data for additional stages are available as well. For each factor, the number of bound regions at the 1% and 25% FDR cutoff are shown for both the Symmetric-null test and the experimental IgG (mock) IP test. For factors with two antibodies, the overlap is shown as the percentage of the 1% FDR bound regions for one antibody that are within 500bp of a 25% FDR bound region from the other antibody.

To access the data, either select from the drop down or click on the stage name in the table for the antibody/stage of interest:

Regulatory Class Transcription
Factor
Antibodies Amino Acids
Recongnized
Stage Symmetric-null TestExperimental IgG IP Test
Number of
Bound Regions
Antibody
% Overlap
Number of
Bound Regions
Antibody
% Overlap
1% FDR25% FDR1% FDR25% FDR
AP early maternal bcd Anti-bcd(1) 56-330 5 619329595.00%%559127689.00%
Anti-bcd(2) 330-489 5 702340493.00%543107093.00%%
cad Anti-cad(1) 1-240 5 15916326N/A11155109N/A
A-P early gap gt Anti-gt(2) 182-353 5 10703968N/A9803973N/A
hb Anti-hb(1) 1-305 5 1832470786.00%1867395475.00%
9 31528503N/AN/AN/AN/A
Anti-hb(2) 306-758 5 1718667592%1259254096.00%
9 5713305N/AN/AN/AN/A
kni Anti-kni(1) 130-280 5 3633097.00%11952798.00%
Anti-kni(2) 281-425 5 197516783.00%20479490.00%
Kr Anti-Kr(1) 1-230 5 35921132396.00%2624525096%
Anti-Kr(2) 350-502 5 40841225593.00%2623483295.00%
A-P early terminal hkb Anti-hkb(1) 1-100 5 10125339N/A8466924N/A
Anti-hkb(2) 101-200 5 6144241N/A2785714N/A
Anti-hkb(3) 201-297 5 6383766N/A2335107N/A
tll Anti-tll(1) 110-259 5 4292650N/A5063436N/A
A-P early gap-like D Anti-D(1) 1-103 5 645216501N/A29037376N/A
A-P pair rule ftz Anti-ftz all 5 4033721N/A86212N/A
hry Anti-h(1) 123-221 5 1704605397.00%831710100.00%
Anti-h(2) 254-337 5 27291097980.00%37157097.00%
prd Anti-prd(1) 355-450 5 2061714596.00%1735344494.00%
Anti-prd(1)* 355-450 5 5751136N/AN/AN/AN/A
Anti-prd(2) 450-613 5 1273569199.00%1360327398.00%
run Anti-run(1) 24-127,
240-318
5 921880977.00%15753458.00%
Anti-run(2) 319-510 5 172290399.00%319697.00%
slp1 Anti-spl1(1) 1-119 5 11716974NA7773242NA
D-V maternal da Anti-da(2) 511-693 5 553414144N/A32846790N/A
dl Anti-dl all 5 935818113N/A35977098N/A
D-V zygotic mad Anti-mad(2) 144-254 5 20410969N/A11N/A
med Anti-med(2) 385-523,
630-713
5 54589273N/A38226166N/A
10 364711848N/AN/AN/AN/A
14 349310130N/AN/AN/AN/A
shn Anti-shn(2) 1617-1750 5 341140047.00%25120492.00%
Anti-shn(3) 2115-2279 5 12136387.00%585890.00%
sna Anti-sna(1) 75-166 5 5964868100.00%284520100.00%
Anti-sna(2) 167-258 5 28001581161.00%954216947.00%
twi Anti-twi(1) 1-178 5 66861748699.00%4706844599.00%
Anti-twi(2) 259-363 5 74161960598.00%4706853299.00%
General
transcription factor
RNA pol II,
unphorphorylated
8WG16 CTD 5 453411790N/A38315081N/A
RNA pol II,
phorphorylated
H14 CTD 5 30237991N/A20253928N/A
TFIIB TFIIB all 5 19436002N/A10012078N/A
Other Z Anti-Z(2) 470-574 5 14288034N/A202530N/A